Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT06760637
An Interventional, Open-Label, Randomized, Multicenter Phase 3 Study of PF-07220060 Plus Letrozole Compared to CDK4/6 Inhibitor Plus Letrozole In Participants Over 18 Years of Age With Hormone Receptor (HR)-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Who Have Not Received Any Prior Systemic Anticancer Treatment for Advanced/Metastatic Disease (FourLight-3)
Status
Open
Conditions
Other
Phases
3
Age Group
Adult
Main Investiagtor
Avila-Lima, Dayra
Practice
Breast
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT06760637
Secondary Trial ID Number
C4391024
Keywords
Treatment